login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
| Disease Info Index | ||||||||||||||||||||||||||
|
|
Hair Loss in Men
Page Options
Hair Loss in Men | |
About |
|
Text 
|
A few men are only in their twenties when they begin to lose hair, but by the time men reach their fifties, more than 50% of them have what doctors would call ‘significant hair loss’. While some of the loss could be caused by scalp infections, diseases, or by habits like pulling out the hair, for most men it falls into the category of male pattern baldness, also called androgenetic alopecia. What is Male Pattern Baldness (MPB) Male pattern baldness is due at least partly to your genes, and an inherited susceptibility to certain chemicals present in the body. It is very common, and it is not a disease, even though for many of us it probably gives as much grief as one.
|
Latest Publication and Research on Hair Loss in Men - Updated on 11/28/2011
Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness. - Published by PubMed
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. - Published by PubMed
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. - Published by PubMed
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. - Published by PubMed
Removal of cadmium by combining deferasirox and desferrioxamine chelators in rats. - Published by PubMed
Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness. - Published by PubMed
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. - Published by PubMed
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. - Published by PubMed
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. - Published by PubMed
Removal of cadmium by combining deferasirox and desferrioxamine chelators in rats. - Published by PubMed
| Share it! |  |
 |
 |
 |
 |
 |
 |
|
|
Comment & Contribute
| Citing this Health Article | ||||||
|
||||||
| News on Hair Loss in Men |
| * Genetic Variation Responsible for Melanesian Blonde Hair |
| * Japanese Researchers Claim to Have Found a Cure for Baldness |
| * Experts Find New Fungus Causing Dandruff |
| * Study Offers Hope for Baldness Cure |
| * Treating Male-pattern Baldness Becomes Easy |
| Total News Item 219 |
Are you a member of Facebook? Become a fan of Medindia and get breaking news delivered to your Facebook page.
